Susquehanna International Group, LLP Generation Bio Co. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Generation Bio Co. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 249,277 shares of GBIO stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
249,277
Previous 92,248
170.22%
Holding current value
$1.01 Million
Previous $36,000
119.44%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding GBIO
# of Institutions
60Shares Held
41.5MCall Options Held
116KPut Options Held
0-
Price T Rowe Associates Inc Baltimore, MD8.46MShares$34.3 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC8.28MShares$33.5 Million0.58% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$13.3 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY2.97MShares$12 Million0.05% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.58MShares$10.5 Million0.0% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $239M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...